Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Boston Therapeutics, Inc.
(OB:
BTHE
)
0.5900
USD
UNCHANGED
Streaming Delayed Price
/ Updated:
8:10 PM EDT, May 21, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.5900
Today's Range
0.5900 - 0.5900
52wk Range
0.3000 - 1.050
Shares Outstanding
19,363,539
Dividend Yield
N/A
Top News
More News
SeeThruEquity Announces Schedule of Presenting Companies for Smallcap and Microcap Investor Summit
November 30, 2012
from
Business Wire News Releases
Diabetes News Highlights Global Pandemic and Millions of Dollars Wasted
November 01, 2012
from
ACCESSWIRE
More News
Read More
Taglich Brothers Initiates Coverage on Boston Therapeutics, Inc.
September 07, 2012
from
Marketwired News Releases
Boston Therapeutics Reports Second Quarter and Six Months 2012 Financial Results
August 14, 2012
from
Marketwired News Releases
Boston Therapeutics to Present Corporate Update at the SeeThruEquity Microcap Investor Forum
July 16, 2012
from
Marketwired News Releases
Boston Therapeutics Completes Enrollment in Phase ll Clinical Trial to Evaluate PAZ320 in Patients With Type 2 Diabetes
June 22, 2012
from
Marketwired News Releases
Boston Therapeutics to Launch SUGARDOWN(R), a Non-Systemic Approach to Managing Blood Glucose, at the Endocrinology Annual Meeting
June 21, 2012
from
Marketwired News Releases
Boston Therapeutics Receives $500,000 Equity Investment
June 14, 2012
from
Marketwired News Releases
Boston Therapeutics Secures DTC Eligibility
June 07, 2012
from
Marketwired News Releases
Boston Therapeutics Receives First Purchase Order From Advance Pharmaceutical
April 18, 2012
from
Marketwired News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here